See also this year's filing and all EDGAR filings for this company.
PDF Report 0001505497_2023_Biorestorative_Therapies_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
Graph
Absolute values for 0001505497, Biorestorative Therapies Inc
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 803,438 |
| 1 | AssetsNonCurrent | 241,760 |
| 2 | AssetsCurrent | 15,128,490 |
| 3 | PropertyPlantAndEquipment | 261,003 |
| 4 | remainder_Assets | 0 |
| 5 | LongTermLiabilities | 162,317 |
| 6 | LiabilitiesCurrent | 440,302 |
| 7 | remainder_Liabilities | 0 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 0 |
| 10 | GeneralAndAdministrativeExpense | 15,580,473 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 0 |
| 15 | ResearchAndDevelopmentExpense | 3,513,352 |
| 16 | remainder_Expenses | 0 |
| 17 | remainder_Revenues | 119,800 |
| 18 | remainder_NetIncome | 479,256 |
| 19 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 16,434,691 |
| 1 | Liabilities | 602,619 |
| 2 | Expenses | 19,093,825 |
| 3 | Revenues | 119,800 |
| 4 | StockholdersEquity | 15,832,072 |
| 5 | NetIncome | -18,494,769 |
| 6 | ComprehensiveNetIncome | -18,494,769 |
| 7 | BaseVar | 18,365,096 |
| 8 | EconomicCapitalRatio | 3.00 |
Edgar->Model Mapping
Feature Distribution
Change over Time
